How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines predispositions in GIPR (rs1800437), and metabolic variants like FTO and MC4R
Semaglutide 2.4 mg injection (Wegovy , Novo Nordisk ), a glucagon-like peptide-1 (GLP-1) receptor agonist, was approved in June 2021 for chronic weight management in adults with overweight and 1 weight-related condition or obesity based on demonstrated weight reduction in clinical trials [10]
Fleur utilizes GRAS (Generally Recognized As Safe) strains with established safety profiles: By transforming these strains, we create engineered bacteria that, once mixed into yogurt for easy consumption and delivered to the gut, produce wild-type GLP-1 that acts as a molecular messenger, binding to GLP-1 receptors and stimulating insulin release while regulating appetite and energy balance
Background diabetes therapy included metformin and sodium-glucose transporter-2 inhibitor (SGLT2i) in 73 Percentage and 27 Percentage of patients, respectively [10]